Lin Y - Search Results

1

Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi.

Tahata S, Singh SV, Lin Y, Hahm ER, Beumer JH, Christner SM, Rao UN, Sander C, Tarhini AA, Tawbi H, Ferris LK, Wilson M, Rose A, Dietz CM, Hughes E, Fahey JW, Leachman SA, Cassidy PB, Butterfield LH, Zarour HM, Kirkwood JM. Tahata S, et al. Among authors: lin y. Cancer Prev Res (Phila). 2018 Jul;11(7):429-438. doi: 10.1158/1940-6207.CAPR-17-0268. Epub 2018 Apr 24. Cancer Prev Res (Phila). 2018. PMID: 29691233 Free PMC article. Clinical Trial.

2

Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma.

Tarhini AA, Moschos SJ, Lin Y, Lin HM, Sander C, Yin Y, Venhaus R, Gajewski TF, Kirkwood JM. Tarhini AA, et al. Among authors: lin hm, lin y. Melanoma Res. 2017 Aug;27(4):342-350. doi: 10.1097/CMR.0000000000000353. Melanoma Res. 2017. PMID: 28489678 Clinical Trial.

3

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma.

Butterfield LH, Vujanovic L, Santos PM, Maurer DM, Gambotto A, Lohr J, Li C, Waldman J, Chandran U, Lin Y, Lin H, Tawbi HA, Tarhini AA, Kirkwood JM. Butterfield LH, et al. Among authors: lin y, lin h. J Immunother Cancer. 2019 Apr 24;7(1):113. doi: 10.1186/s40425-019-0552-x. J Immunother Cancer. 2019. PMID: 31014399 Free PMC article. Clinical Trial.

4

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Najjar YG, McCurry D, Lin H, Lin Y, Zang Y, Davar D, Karunamurthy A, Drabick JJ, Neves RI, Butterfield LH, Ernstoff MS, Puzanov I, Skitzki JJ, Bordeaux J, Summit IB, Bender JO, Kim JY, Chen B, Sarikonda G, Pahuja A, Tsau J, Alfonso Z, Laing C, Pingpank JF, Holtzman MP, Sander C, Rose A, Zarour HM, Kirkwood JM, Tarhini AA. Najjar YG, et al. Among authors: lin y, lin h. Clin Cancer Res. 2021 Aug 1;27(15):4195-4204. doi: 10.1158/1078-0432.CCR-20-4301. Epub 2021 Mar 22. Clin Cancer Res. 2021. PMID: 33753453 Free PMC article.

5

Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.

Tarhini AA, Leng S, Moschos SJ, Yin Y, Sander C, Lin Y, Gooding WE, Kirkwood JM. Tarhini AA, et al. Among authors: lin y. J Immunother. 2012 May;35(4):359-66. doi: 10.1097/CJI.0b013e31825481fe. J Immunother. 2012. PMID: 22495394 Free PMC article. Clinical Trial.

6

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.

Tarhini AA, Edington H, Butterfield LH, Lin Y, Shuai Y, Tawbi H, Sander C, Yin Y, Holtzman M, Johnson J, Rao UN, Kirkwood JM. Tarhini AA, et al. Among authors: lin y. PLoS One. 2014 Feb 3;9(2):e87705. doi: 10.1371/journal.pone.0087705. eCollection 2014. PLoS One. 2014. PMID: 24498358 Free PMC article.

7

Unfolding the mutational landscape of human melanoma.

Davar D, Lin Y, Kirkwood JM. Davar D, et al. Among authors: lin y. J Invest Dermatol. 2015 Mar;135(3):659-662. doi: 10.1038/jid.2014.467. J Invest Dermatol. 2015. PMID: 25666674 Free PMC article.

8

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma.

Tarhini AA, Zahoor H, Lin Y, Malhotra U, Sander C, Butterfield LH, Kirkwood JM. Tarhini AA, et al. Among authors: lin y. J Immunother Cancer. 2015 Sep 15;3:39. doi: 10.1186/s40425-015-0081-1. eCollection 2015. J Immunother Cancer. 2015. PMID: 26380086 Free PMC article.

9

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab.

Retseck J, VanderWeele R, Lin HM, Lin Y, Butterfield LH, Tarhini AA. Retseck J, et al. Among authors: lin hm, lin y. J Immunother Cancer. 2016 Jun 21;4:38. doi: 10.1186/s40425-016-0141-1. eCollection 2016. J Immunother Cancer. 2016. PMID: 27330811 Free PMC article.

10

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.

Najjar YG, Ding F, Lin Y, VanderWeele R, Butterfield LH, Tarhini AA. Najjar YG, et al. Among authors: lin y. J Transl Med. 2017 Feb 21;15(1):39. doi: 10.1186/s12967-017-1140-9. J Transl Med. 2017. PMID: 28222797 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,636 results

Search Page

Filters